Products

What will AGI do for Artesunate?

This classification denotes an antiprotozoal agent with the molecular formula C19H28O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60W3249T9M, chemically known as 4-oxo-4-(((3r,5as,6r,8as,9r,10s,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate but generally known as artesunate, which bears US NIH Compound Identifier 65664. European Medicines Agency schedules Artesunate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05576MIG. The term ARTESUNATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, No. 1, 2006, List 55). World Health Organization schedules artesunate in its Anatomical Therapeutic Chemical (ATC) Classification. ARTESUNATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule artesunate under HS 29329970 and SITC 51569. As of Q4 2014, ARTESUNATE remains the US FDA Preferred Term for this commodity. Artesunate bears US NLM identifiers UMLS ID C0052432 and NCI Concept Code C73005. SMILES: O1OC2(OC3OC(OC(=O)CCC(=O)O)C(C4C13C(C(CC4)C)CC2)C)C.